Sunday - June 2, 2024

Using Electrophoresis for Disease Detection Based on Controlled Molecular Charge

2024-04-30

ALEXANDRIA, Virginia, April 30 -- HEMEX HEALTH, INC., Portland, Oregon has been assigned a patent (No. US 11971384 B2, initially filed Oct. 18, 2021) developed by six inventors Peter Galen, Portland, Oregon; Ariane Elizabeth Erickson, Portland, Oregon; David Richard Bell, Issaquah, Washington; Matthew Christian Lind, Portland, Oregon; Tyler Witte, Portland, Oregon; and Umut Atakan Gurkan, Shaker Heights, Ohio, for "Using electrophoresis for disease detection based on controlled molecular charge . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Using Electrophoresis for Disease Detection Based on Controlled Molecular Charge

Information Request Form

Copyright Targeted News Service 2024